| 注册
首页|期刊导航|实用临床医药杂志|蛋白酶体抑制剂MG132对Caov-3细胞中NF-κB、CycLinD1表达的影响

蛋白酶体抑制剂MG132对Caov-3细胞中NF-κB、CycLinD1表达的影响

马忠平 顾光华 贾玉芳

实用临床医药杂志2011,Vol.15Issue(17):46-48,3.
实用临床医药杂志2011,Vol.15Issue(17):46-48,3.

蛋白酶体抑制剂MG132对Caov-3细胞中NF-κB、CycLinD1表达的影响

The expression of NF-κB、CyclinD1 in Caov-3 cells after using proteasome inhibitor MG132

马忠平 1顾光华 1贾玉芳1

作者信息

  • 1. 江苏省溧阳市人民医院妇产科,江苏溧阳,213300
  • 折叠

摘要

Abstract

Objective To study the expression of NF-κB and CyclinDl in human ovarian cancer Caov-3 cells after using proteasome inhibitor MG132. Methods Cell culture and immuno histochemical assessment were performed for alterations in expression of NF - κB and CyclinD1. Re sults The expression level of NF - κB and CyclinDl decreased in Caov - 3 cells after being treated with MG132 for 24 hours. The differences were statistically significant (P<0.01). Conclusion MG132 could significantly induce the apoptosis of Caov - 3 cells. The part of anti - tumor mecha nism of MG132 suppresses tumor growth and induces apoptosis by inhibiting expression of NF-κB and CyclinD1.

关键词

MG132/Caov-3/细胞培养/免疫组化/NF-κB/CycLinD1

Key words

MG132/ Caov-3/ cell culture/ immunohistochemistry/ NF~κB/ CyclinDl

分类

医药卫生

引用本文复制引用

马忠平,顾光华,贾玉芳..蛋白酶体抑制剂MG132对Caov-3细胞中NF-κB、CycLinD1表达的影响[J].实用临床医药杂志,2011,15(17):46-48,3.

实用临床医药杂志

OACSTPCD

1672-2353

访问量0
|
下载量0
段落导航相关论文